Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.
about
Increasing value and reducing waste in biomedical research regulation and managementEfficiency and effectiveness evaluation of an automated multi-country patient count cohort systemImplementing clinical trials on an international platform: challenges and perspectives.Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization"You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.International research ethics education.Introduction: the Fogarty International Research Ethics Education and Curriculum Development Program in historical contextGlobal pharmacogenomics: where is the research taking us?The 50 Most Cited Articles in Orthopedic Cartilage Surgery.The GCP guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa.Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.Impediments to clinical research in the United States.Damage to important clinical trials by over-regulation.A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
P2860
Q28657841-70BBA26A-DC98-4887-B35F-FE2182C708D3Q35619216-216D8FEC-07CD-41E2-B0D7-0C5B49543CCAQ35663409-EAB23C77-05BC-4690-92A8-323E2C80BCD7Q35933528-AC2FFD61-BE33-445F-8511-D132AB71B792Q36194240-82A94107-4889-4885-B6F1-53EA55B3FBF3Q36310614-83912E24-CEFF-4043-879D-598FE723EE28Q36444747-65C6AFDA-0AEA-4620-9A85-C58BBCE7D944Q36781288-ADC4AF47-8022-43AE-9CA7-C7F7E9DE8D33Q38192063-7E365058-2698-4664-B482-23BABD27D193Q38885241-9DE37D8D-281F-4A7B-A103-84955DFE5F2EQ39562749-C509AE73-2426-43DE-B1EB-697118F3FED6Q43184639-20893B17-FA0C-4D70-A40C-A54972DC4EA8Q48485541-00B2E9F1-454D-4BEF-B09B-17E385DAB835Q48735399-2B35DA32-D484-4A75-9F83-285EF69ADEABQ55023653-C4B327FE-104F-48FF-9382-A0D29998F9E2
P2860
Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Bridging the gap: improving cl ...... oducts for neglected diseases.
@en
Bridging the gap: improving cl ...... oducts for neglected diseases.
@nl
type
label
Bridging the gap: improving cl ...... oducts for neglected diseases.
@en
Bridging the gap: improving cl ...... oducts for neglected diseases.
@nl
prefLabel
Bridging the gap: improving cl ...... oducts for neglected diseases.
@en
Bridging the gap: improving cl ...... oducts for neglected diseases.
@nl
P2860
P356
P1433
P1476
Bridging the gap: improving cl ...... oducts for neglected diseases.
@en
P2093
Ernst Berndt
Thomas J Bollyky
P2860
P304
P356
10.1177/1740774510386390
P577
2010-11-25T00:00:00Z